Grant: Master's Award: Canada Graduate Scholarships
University of Ottawa
$17,500.00
Modulation of Ca2+/Calmodulin-Dependent Protein Kinase Isoform II (CaMKII) Localization and Activity
FY 2012-13
Summary
For people with certain heart conditions, such as arrhythmias and heart failure, the amount of calcium in compartments within the human heart tends to be poorly controlled. It has been found that these poorly regulated calcium levels are linked to an overabundance of CaMKII (a cardiac protein). Another protein has been recently found which inhibits the deleterious effect of CaMKII on the heart. We will continue to study how this novel protein inhibits CaMKII by examining the interaction of these proteins in mice hearts. Through an increased understanding of the mechanism of CaMKII inhibition, we will design a human heart drug which will act similarly to the naturally produced inhibitor.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
279773
Name
Paige Brian
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Modulation of Ca2+/Calmodulin-Dependent Protein Kinase Isoform II (CaMKII) Localization and Activity
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Arrhythmia; Bacterial Transformation; Calcium Binding Curve; Calcium Ion Channel; Cardiomyopathy; Cell Culture; Excitation-Contraction Coupling; Literature Review; Phosphorylation Assay; Western Blotting
Abstract
For people with certain heart conditions, such as arrhythmias and heart failure, the amount of calcium in compartments within the human heart tends to be poorly controlled. It has been found that these poorly regulated calcium levels are linked to an overabundance of CaMKII (a cardiac protein). Another protein has been recently found which inhibits the deleterious effect of CaMKII on the heart. We will continue to study how this novel protein inhibits CaMKII by examining the interaction of these proteins in mice hearts. Through an increased understanding of the mechanism of CaMKII inhibition, we will design a human heart drug which will act similarly to the naturally produced inhibitor.
Competitiondate
201302
Approvedterm2
1 yr 0 mth
Pinamesdelim
Paige, Brian
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~